Then, through LASSO regression, 5 genes (ADD3, GRHPR, KLF13, RHBDL1 and SLC9A9) closely related to the prognosis of WHO Grade 4 glioma patients were selected (Fig. 5B, C). This evidence concerns the gene RHBDL1 and central nervous system cancer.